Orexin/Hypocretin Type 2 Receptor (HCRTR2) Gene as a Candidate Gene in Sertraline-Associated Insomnia in Depressed Patients
Negar Firouzabadi,1,2 Niloofar Navabzadeh,1 Ebrahim Moghimi-Sarani,3 Maral Haghnegahdar1 1Department of Pharmacology and Toxicology, School of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; 2Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran;...
Guardado en:
Autores principales: | Firouzabadi N, Navabzadeh N, Moghimi-Sarani E, Haghnegahdar M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/480122a92ed24f73a3287c26258002f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The hypocretin/orexin system in sleep disorders: preclinical insights and clinical progress
por: Chow M, et al.
Publicado: (2016) -
Possible sertraline-induced extrapyramidal adverse effects in an adolescent
por: Wang LF, et al.
Publicado: (2016) -
Novel class of medications, orexin receptor antagonists, in the treatment of insomnia – critical appraisal of suvorexant
por: Norman JL, et al.
Publicado: (2016) -
Tumor cell apoptosis mediated by the orexins
por: A. S. Diatlova, et al.
Publicado: (2021) -
Research progress on the mechanism of orexin in pain regulation in different brain regions
por: Kang Xianhui, et al.
Publicado: (2021)